125 related articles for article (PubMed ID: 34580051)
1. Dosimetry and outcomes in patients receiving radiotherapy for synchronous bilateral breast cancers.
McKenzie E; Razvi Y; Bosnic S; Wronski M; Zhang L; Karam I; Donovan E; Milton L; Behroozian T; Drost L; Yee C; Wong G; Lam E; Chow E
J Med Imaging Radiat Sci; 2021 Dec; 52(4):527-543. PubMed ID: 34580051
[TBL] [Abstract][Full Text] [Related]
2. Trends and Correlates of Mean Lung Dose in Patients Receiving Breast Radiotherapy in a Single Institution from 2014 to 2018.
McKenzie E; Razvi Y; Wronski M; Zhang L; Bosnic S; Vesprini D; Paszat L; Rakovitch E; Drost L; Yee C; Russell S; McCann C; Chow E
Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):647-655. PubMed ID: 32540281
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Mean Heart Dose in Patients Receiving Breast Radiotherapy from 2011 to 2018 in a Single Institution.
Razvi Y; McKenzie E; Wronski M; Zhang L; Vesprini D; Bosnic S; Paszat L; Rakovitch E; Drost L; Yee C; Russell S; McCann C; Chow E
J Med Imaging Radiat Sci; 2020 Sep; 51(3):379-393. PubMed ID: 32362536
[TBL] [Abstract][Full Text] [Related]
4. Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?
Yadav R; Lal P; Agarwal S; Misra S; Verma M; Das KJM; Senthil Kumar SK; Kumar A; Mishra SK; Agarwal A; Agarwal G; Mishra A; Chand G; Verma AK; Kumar S
J Cancer Res Ther; 2020; 16(6):1314-1322. PubMed ID: 33342790
[TBL] [Abstract][Full Text] [Related]
5. Synchronous bilateral breast cancer treated with a 3-week hypofractionated radiotherapy schedule: clinical and dosimetric outcomes.
Gadea J; Ortiz I; Roncero R; Alastuey I; Mestre F; Aymar N; Maturana JE; Garcia C; Mateu L; Pardo J
Clin Transl Oncol; 2021 Sep; 23(9):1915-1922. PubMed ID: 33830442
[TBL] [Abstract][Full Text] [Related]
6. Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018.
Lam E; Chan S; Karam I; Lee J; Wong G; Zhang L; Vesprini D; Wronski M; Chin L; Razvi Y; McKenzie E; Rakovitch E; Chow E
Clin Breast Cancer; 2020 Oct; 20(5):e612-e617. PubMed ID: 32321680
[TBL] [Abstract][Full Text] [Related]
7. The potential benefits from respiratory gating for breast cancer patients regarding target coverage and dose to organs at risk when applying strict dose limits to the heart: results from the DBCG HYPO trial.
Berg M; Lorenzen EL; Jensen I; Thomsen MS; Lutz CM; Refsgaard L; Nissen HD; Offersen BV
Acta Oncol; 2018 Jan; 57(1):113-119. PubMed ID: 29205080
[TBL] [Abstract][Full Text] [Related]
8. Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices.
Pierce LJ; Feng M; Griffith KA; Jagsi R; Boike T; Dryden D; Gustafson GS; Benedetti L; Matuszak MM; Nurushev TS; Haywood J; Radawski JD; Speers C; Walker EM; Hayman JA; Moran JM;
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1154-1161. PubMed ID: 28927756
[TBL] [Abstract][Full Text] [Related]
9. Patient-Specific Heart Constraint: A Tool for Optimization and Evaluation of Mean Heart Dose in Breast Cancer Patients.
Ward R; West K; Latty D; Beldham-Collins R; Jia D; Wang W; Cross S; Gebski V; Ahern V; Stuart K
Pract Radiat Oncol; 2021; 11(2):e154-e162. PubMed ID: 33130033
[TBL] [Abstract][Full Text] [Related]
10. Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy.
Tang S; Otton J; Holloway L; Delaney GP; Liney G; George A; Jameson M; Tran D; Batumalai V; Thomas L; Koh ES
Radiother Oncol; 2019 Mar; 132():257-265. PubMed ID: 30446318
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
[TBL] [Abstract][Full Text] [Related]
12. Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.
Fiorentino A; Mazzola R; Naccarato S; Giaj-Levra N; Fersino S; Sicignano G; Tebano U; Ricchetti F; Ruggieri R; Alongi F
Radiol Med; 2017 Jun; 122(6):464-471. PubMed ID: 28224401
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From China.
Wang SL; Fang H; Hu C; Song YW; Wang WH; Jin J; Liu YP; Ren H; Liu J; Li GF; Du XH; Tang Y; Jing H; Ma YC; Huang Z; Chen B; Tang Y; Li N; Lu NN; Qi SN; Yang Y; Sun GY; Liu XF; Li YX
J Clin Oncol; 2020 Nov; 38(31):3604-3614. PubMed ID: 32780661
[TBL] [Abstract][Full Text] [Related]
14. Clinical and cosmetic results of breast boost radiotherapy in early breast cancer: a randomized study between electron and photon.
Rajan SS; Sharma SC; Kumar N; Kumar R; Singh G; Singh R; Tomar P
J Cancer Res Ther; 2014; 10(4):889-95. PubMed ID: 25579524
[TBL] [Abstract][Full Text] [Related]
15. Assessing radiation exposure of the left anterior descending artery, heart and lung in patients with left breast cancer: A dosimetric comparison between multicatheter accelerated partial breast irradiation and whole breast external beam radiotherapy.
Chan TY; Tan PW; Tan CW; Tang JI
Radiother Oncol; 2015 Dec; 117(3):459-66. PubMed ID: 26328940
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
[TBL] [Abstract][Full Text] [Related]
17. Novel 10-fraction breast irradiation in prone and supine position: technical, dosimetric and clinical evaluation.
Guenzi M; Bosetti D; Lamanna G; Siffredi G; Bonzano E; Gusinu M; Garelli S; Pupillo F; Corvò R
Tumori; 2015; 101(2):154-60. PubMed ID: 25838252
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of helical tomotherapy, volumetric-modulated arc therapy, intensity-modulated radiotherapy, and field-in-field technique for synchronous bilateral breast cancer.
Cheng HW; Chang CC; Shiau AC; Wang MH; Tsai JT
Med Dosim; 2020 Autumn; 45(3):271-277. PubMed ID: 32122694
[TBL] [Abstract][Full Text] [Related]
20. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: report of a prospective trial.
Eldredge-Hindy H; Lockamy V; Crawford A; Nettleton V; Werner-Wasik M; Siglin J; Simone NL; Sidhu K; Anne PR
Pract Radiat Oncol; 2015; 5(1):4-10. PubMed ID: 25567159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
